aibioCuranex repays $400,000 in loans from its CEO's wife weeks after its IPO
Tickers CURX
Curanex paid $408,537.32 on two notes held by its secretary, Dian Ying Jing, the wife of its chief executive. The payments came on September 23 and 24, 2025, well before the notes matured in 2027.
Key facts
- Company
- Curanex Pharmaceuticals Inc (NASDAQ: CURX)
- News type
- Financings
- Primary source
- Curanex 8-K
Curanex Pharmaceuticals Inc. repaid two promissory notes owed to Dian Ying Jing, its secretary and the wife of chief executive Jun Liu, in late September 2025, according to a Form 8-K signed September 29, 2025. The company prepaid the first note on September 23 and the second on September 24. The total paid was $408,537.32, which includes $400,000 of principal and $8,537.32 of accrued interest. The company says the repayment eliminated its outstanding debt and avoided about $26,182.68 of interest that would have accrued until the maturity dates.
The notes were issued in 2025, a few months before the company's initial public offering. Ms. Jing lent $200,000 on February 4, 2025, under a note that was amended on May 30, 2025. She lent a second $200,000 on May 21, 2025. Each note carried an interest rate of 4.34% a year. The first note was due February 4, 2027, and the second on May 23, 2027. The 8-K says both notes could be prepaid without penalty or premium.
The offering that came before
The repayment followed Curanex's public offering. The company closed the offering of 3,750,000 shares at $4.00 a share on August 27, 2025, and the underwriters then exercised their option for 562,500 more shares in full, with that closing on September 12, 2025. After the August closing the company had 27,750,000 shares outstanding. The September 25 issuance described below cites 28,312,500 shares outstanding at that time.
The 8-K does not say where the money for the prepayment came from. The repayment came weeks after the offering closed, but the filing does not link the two. The filings do not give a cash balance for September 2025, so this story cannot say how much cash the company had left after the repayment.
Related-party status
The 8-K describes Ms. Jing as the company's secretary and the wife of the chief executive officer. Loans from an executive's family are a related-party arrangement, and the company disclosed the notes as loans it had received "as previously disclosed." The filing does not describe any review by the board or a committee of the board, and the sources give no approval record for either loan.
The company's own description of the loans is limited to their size, rate, maturity and repayment. The 8-K does not describe how the company used the $400,000, what it would have paid in interest through 2027 under the original terms beyond the $26,182.68 figure, or whether any other loans from insiders are outstanding.
A second sale of stock in the same week
The 8-K also reports a separate issuance. On September 25, 2025, Curanex issued 28,312 common shares to Xiaohong Song, an investor who entered into an amended and restated subscription agreement with the company on November 27, 2024. Under that agreement, Mr. Song subscribed for $200,000 of stock, and the shares were issued after the IPO closed. The company calls the shares an exempt issuance under Section 4(a)(2) of the Securities Act, which covers transactions by an issuer that do not involve a public offering. The 8-K says the shares represent 0.1% of the 28,312,500 shares outstanding at the time.
The filings do not explain why the subscription was held until after the IPO. They also do not say whether any other subscriptions were converted into shares at the same time.
What comes next
The filings do not say whether the company plans further repayments, new insider loans, or additional stock sales. The 8-K gives no timetable for any of them, and the repaid notes no longer appear on the company's debt. The filing is the company's own account of the transaction, and the story has no independent source for the loan terms or the use of the money.